Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.88 USD | -1.11% | +4.59% | -21.00% |
May. 23 | Transcript : Theravance Biopharma, Inc. - Special Call | |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
Financials (USD)
Sales 2024 * | 78.81M | Sales 2025 * | 101M | Capitalization | 432M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | 1M | EV / Sales 2024 * | 4.3 x |
Net cash position 2024 * | 93M | Net cash position 2025 * | - | EV / Sales 2025 * | 4.29 x |
P/E ratio 2024 * |
-20.9
x | P/E ratio 2025 * |
42.8
x | Employees | 99 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.45% |
Latest transcript on Theravance Biopharma, Inc.
1 day | -1.11% | ||
1 week | +4.59% | ||
Current month | +3.02% | ||
1 month | -7.50% | ||
3 months | +1.60% | ||
6 months | -15.51% | ||
Current year | -21.00% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 14-05-31 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 14-05-31 |
Eran Broshy
BRD | Director/Board Member | 65 | 14-06-01 |
Director/Board Member | 59 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.03% | 746 M€ | -.--% | - | |
0.02% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 8.88 | -1.11% | 126,746 |
24-06-05 | 8.98 | +4.06% | 702,247 |
24-06-04 | 8.63 | +1.17% | 214,755 |
24-06-03 | 8.53 | -1.04% | 235,280 |
24-05-31 | 8.62 | +1.53% | 347,486 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.00% | 432M | |
+43.64% | 754B | |
+39.55% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.79% | 217B | |
-1.64% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- TBPH Stock